{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:20:35Z","timestamp":1787980835593,"version":"build-2784847793"},"reference-count":43,"publisher":"Pleiades Publishing Ltd","issue":"8","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1134\/s0006297925603880","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:42:51Z","timestamp":1784032971000},"page":"1396-1405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroprotective Effect of Subconjunctival Melatonin Injections in 6-Hydroxydopamine-Induced Neurotoxic Eye Damage"],"prefix":"10.1134","volume":"91","author":[{"given":"Tatyana A.","family":"Pavlenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya B.","family":"Chesnokova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Lisovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Beznos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey V.","family":"Grigoryev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"3056_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.21516\/2072-0076-2024-17-3-7-12","volume":"3","author":"V. V. Neroev","year":"2024","unstructured":"Neroev, V. V., Mikhailova, L. A., Malishevskaya, T. N., Petrov, S. Yu., and Filipova, O. M. (2024) Epidemiology of glaucoma in the Russian Federation [in Russian], Russ. Ophthalmol.\u00a0J., 3, 7-12, \nhttps:\/\/doi.org\/10.21516\/2072-0076-2024-17-3-7-12.","journal-title":"Russ. Ophthalmol.\u00a0J."},{"key":"3056_CR2","doi-asserted-by":"publisher","first-page":"714","DOI":"10.24412\/2312-2935-2024-3-713-730","volume":"3","author":"U. S. Plyaskina","year":"2024","unstructured":"Plyaskina, U. S., and Fomina, A. V. (2024) Epidemiological aspects of age-related macular degeneration and senile cataract in Russia and the world [in Russian], Mod. Probl. Health Care Med. Stat., 3, 714-730, \nhttps:\/\/doi.org\/10.24412\/2312-2935-2024-3-713-730.","journal-title":"Mod. Probl. Health Care Med. Stat."},{"key":"3056_CR3","doi-asserted-by":"publisher","DOI":"10.21045\/2071-5021-2025-71-1-2","volume":"71","author":"Yu. V. Mikhailova","year":"2025","unstructured":"Mikhailova, Yu. V., Sterlikov, S. A., Zelenova, O. V., Oskov, Yu. I., and Abramov, S. I. (2025) Epidemiology of diabetic retinopathy in the Russian Federation [in Russian], Soc. Aspects Populat. Health, 71, 2, \nhttps:\/\/doi.org\/10.21045\/2071-5021-2025-71-1-2.","journal-title":"Soc. Aspects Populat. Health"},{"key":"3056_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41380-024-02691-6","volume":"1","author":"Z. Zhang","year":"2025","unstructured":"Zhang, Z., Xue, P., Bendlin, B. B., Zetterberg, H., De Felice, F., Tan, X., and Benedict, C. (2025) Melatonin: a potential nighttime guardian against Alzheimer\u2019s, Mol. Psychiatry, 1, 237-250, \nhttps:\/\/doi.org\/10.1038\/s41380-024-02691-6.","journal-title":"Mol. Psychiatry"},{"key":"3056_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.650597","volume":"12","author":"S. P\u00e9rez-Lloret","year":"2021","unstructured":"P\u00e9rez-Lloret, S., and Cardinali, D. P. (2021) Melatonin as a chronobiotic and cytoprotective agent in Parkinson\u2019s disease, Front. Pharmacol., 12, 650597, \nhttps:\/\/doi.org\/10.3389\/fphar.2021.650597.","journal-title":"Front. Pharmacol."},{"key":"3056_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/biology15020189","volume":"2","author":"Y. Bao","year":"2026","unstructured":"Bao, Y., Miao, G., He, N., Bao, X., Shi, Z., Hu, C., Liu, X., Wang, B., and Sun, C. (2026) Melatonin as a guardian of mitochondria: mechanisms and therapeutic potential in neurodegenerative diseases, Biology (Basel), 2, 189, \nhttps:\/\/doi.org\/10.3390\/biology15020189.","journal-title":"Biology (Basel)"},{"key":"3056_CR7","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1007\/s00210-024-03575-w","volume":"4","author":"J. Sun","year":"2025","unstructured":"Sun, J., Liu, Y., and Chen, Z. (2025) Melatonin and retinal cell damage: molecular and biological functions, Naunyn Schmiedebergs Arch. Pharmacol., 4, 3199-3212, \nhttps:\/\/doi.org\/10.1007\/s00210-024-03575-w.","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"3056_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.21516\/2072-0076-2016-9-4-106-111","volume":"4","author":"N. B. Chesnokova","year":"2016","unstructured":"Chesnokova, N. B., and Beznos, O. V. (2016) Melatonin: role in the regulation of physiological processes in the eye in norm and pathology, prospects of application (literature review) [in Russian], Russ. Ophthalmol.\u00a0J., 4, 106-111, \nhttps:\/\/doi.org\/10.21516\/2072-0076-2016-9-4-106-111.","journal-title":"Russ. Ophthalmol.\u00a0J."},{"key":"3056_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12643","volume":"68","author":"H. H. Di\u00e9guez","year":"2020","unstructured":"Di\u00e9guez, H. H., Gonz\u00e1lez Fleitas, M. F., and Aranda, M. L. (2020) Melatonin protects the retina from experimental nonexudative age-related macular degeneration in mice, J.\u00a0Pineal Res., 68, e12643, \nhttps:\/\/doi.org\/10.1111\/jpi.12643.","journal-title":"J.\u00a0Pineal Res."},{"key":"3056_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051213","volume":"5","author":"X. Hou","year":"2025","unstructured":"Hou, X., and Pan, Y. (2025) Melatonin in glaucoma: integrative mechanisms of intraocular pressure control and neuroprotection, Biomedicines, 5, 1213, \nhttps:\/\/doi.org\/10.3390\/biomedicines13051213.","journal-title":"Biomedicines"},{"key":"3056_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010100","volume":"1","author":"K. Oliveira-Abreu","year":"2021","unstructured":"Oliveira-Abreu, K., Cipolla-Neto, J., and Leal-Cardoso, J. H. (2021) Effects of melatonin on diabetic neuropathy and retinopathy, Int.\u00a0J. Mol. Sci., 1, 100, \nhttps:\/\/doi.org\/10.3390\/ijms23010100.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"3056_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ph17040441","volume":"4","author":"D. Rusciano","year":"2024","unstructured":"Rusciano, D., and Russo, C. (2024) The therapeutic trip of melatonin eye drops: from the ocular surface to the retina, Pharmaceuticals (Basel), 4, 441, \nhttps:\/\/doi.org\/10.3390\/ph17040441.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3056_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/14728222.2020.1737015","volume":"4","author":"S. Mehrzadi","year":"2020","unstructured":"Mehrzadi, S., Hemati, K., Reiter, R.\u00a0J., and Hosseinzadeh, A. (2020) Mitochondrial dysfunction in age-related macular degeneration: melatonin as a potential treatment, Exp. Opin. Ther. Targets, 4, 359-378, \nhttps:\/\/doi.org\/10.1080\/14728222.2020.1737015.","journal-title":"Exp. Opin. Ther. Targets"},{"key":"3056_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.lfs.2018.12.053","volume":"218","author":"C. Del Valle Bessone","year":"2019","unstructured":"Del Valle Bessone, C., Fajreldines, H. D., de Barboza, G.\u00a0E.\u00a0D., Tolosa de Talamoni, N. G., Allemandi, D.\u00a0A., Carpentieri, A.\u00a0R., and Quinteros, D.\u00a0A. (2019) Protective role of melatonin on retinal ganglionar cell: in\u00a0vitro and in\u00a0vivo evidences, Life Sci., 218, 233-240, \nhttps:\/\/doi.org\/10.1016\/j.lfs.2018.12.053.","journal-title":"Life Sci."},{"key":"3056_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17010085","volume":"1","author":"S. M. Martinez","year":"2025","unstructured":"Martinez, S. M., Inda, A., R\u00edos, M. N., Bessone, C. D. V., Bruera Bossio, A., Guido, M.\u00a0E., Luna Pinto, J.\u00a0D., Allemandi, D.\u00a0A., and Quinteros, D.\u00a0A. (2025) Neuroprotective effect of melatonin loaded in human serum albumin nanoparticles applied subconjunctivally in a retinal degeneration animal model, Pharmaceutics, 1, 85, \nhttps:\/\/doi.org\/10.3390\/pharmaceutics17010085.","journal-title":"Pharmaceutics"},{"key":"3056_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252313196","volume":"23","author":"M. Ntikoudi","year":"2024","unstructured":"Ntikoudi, M., Farmaki, T. M., and Tziomalos, K. (2024) Dopamine: a new player in the pathogenesis of diabetic retinopathy? Int. J. Mol. Sci., 23, 13196, \nhttps:\/\/doi.org\/10.3390\/ijms252313196.","journal-title":"Int. J. Mol. Sci."},{"key":"3056_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07142-7","volume":"1","author":"S. F. Wang","year":"2017","unstructured":"Wang, S. F., Liu, L. F., Wu, M. Y., Cai, C. Z., Su, H., Tan, J., Lu, J.\u00a0H., and Li, M. (2017) Baicalein prevents 6-OHDA\/ascorbic acid-induced calcium-dependent dopaminergic neuronal cell death, Sci. Rep., 1, 8398, \nhttps:\/\/doi.org\/10.1038\/s41598-017-07142-7.","journal-title":"Sci. Rep."},{"key":"3056_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.21516\/2072-0076-2024-17-2-55-61","volume":"2","author":"T. A. Pavlenko","year":"2024","unstructured":"Pavlenko, T. A., Chesnokova, N. B., Beznos, O. V., Grigoryev, A. V., Okhotsimskaya, T. D., and Shikareva, N. N. (2024) Modeling the early stage of the neurodegenerative process in the retina by local administration of a dopaminergic neurotoxin [in Russian], Russ. Ophthalmol.\u00a0J., 2, 55-61, \nhttps:\/\/doi.org\/10.21516\/2072-0076-2024-17-2-55-61.","journal-title":"Russ. Ophthalmol.\u00a0J."},{"key":"3056_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF01203705","volume":"1","author":"G. Lafond","year":"1994","unstructured":"Lafond, G., Cao, W., Drumheller, A., Jolicoeur, F. B., Zaharia, M., and Realbrunette, J. (1994) Selective effects of retinal dopamine depletion on partial ischemia-induced electroretinographic hyperresponses in rabbits, Doc. Ophthalmol., 1, 89-97, \nhttps:\/\/doi.org\/10.1007\/BF01203705.","journal-title":"Doc. Ophthalmol."},{"key":"3056_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130036","volume":"6","author":"A. R. Wyatt","year":"2015","unstructured":"Wyatt, A. R., Kumita, J. R., Farrawell, N. E., Dobson, C.\u00a0M., and Wilson, M.\u00a0R. (2015) Alpha-2-macroglobulin is acutely sensitive to freezing and lyophilization: implications for structural and functional studies, PLoS One, 6, e0130036, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0130036.","journal-title":"PLoS One"},{"key":"3056_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"1","author":"O. Lowry","year":"1951","unstructured":"Lowry, O., Rozebrough, N., Farr, A., and Randell, R. (1951) Protein measurement with the Folin phenol reagent, J. Biol. Chem., 1, 265-275, \nhttps:\/\/doi.org\/10.1016\/S0021-9258(19)52451-6.","journal-title":"J. Biol. Chem."},{"key":"3056_CR22","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3233\/JAD-215231","volume":"3","author":"S. Tran","year":"2022","unstructured":"Tran, S., Kuruppu, S., and Rajapakse, N. W. (2022) Chronic renin-angiotensin system activation induced neuroinflammation: common mechanisms underlying hypertension and dementia? J.\u00a0Alzheimers Dis., 3, 943-955, \nhttps:\/\/doi.org\/10.3233\/JAD-215231.","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"3056_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/biology15020201","volume":"2","author":"Y. Y. Zhang","year":"2026","unstructured":"Zhang, Y. Y., Sun, Q. F., Bai, W., and Yao, J. (2026) Retinal astrocytes: key coordinators of developmental angiogenesis and neurovascular homeostasis in health and disease, Biology (Basel), 2, 201, \nhttps:\/\/doi.org\/10.3390\/biology15020201.","journal-title":"Biology (Basel)"},{"key":"3056_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00441-022-03670-5","volume":"2","author":"D. Asano","year":"2022","unstructured":"Asano, D., Kojima, M., Morita, A., and Nakahara, T. (2022) Tumor necrosis factor-\u03b1 and matrix metalloproteinase-9 cooperatively exacerbate neurovascular degeneration in the neonatal rat retina, Cell Tissue Res., 2, 173-187, \nhttps:\/\/doi.org\/10.1007\/s00441-022-03670-5.","journal-title":"Cell Tissue Res."},{"key":"3056_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejpb.2021.06.001","volume":"166","author":"A. Allmendinger","year":"2021","unstructured":"Allmendinger, A., Butt, Y. L., and Mueller, C. (2021) Intraocular pressure and injection forces during intravitreal injection into enucleated porcine eyes, Eur.\u00a0J. Pharm. Biopharm., 166, 87-93, \nhttps:\/\/doi.org\/10.1016\/j.ejpb.2021.06.001.","journal-title":"Eur.\u00a0J. Pharm. Biopharm."},{"key":"3056_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1748-1716.2010.02089.x","volume":"2","author":"C. H. Hoyle","year":"2010","unstructured":"Hoyle, C. H., and Pintor, J. J. (2010) Diadenosine tetraphosphate protects sympathetic terminals from 6-hydroxydopamine-induced degeneration in the eye, Acta Physiol. (Oxf), 2, 205-210, \nhttps:\/\/doi.org\/10.1111\/j.1748-1716.2010.02089.x.","journal-title":"Acta Physiol. (Oxf)"},{"key":"3056_CR27","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1111\/bph.14971","volume":"9","author":"H. A. Alkozi","year":"2020","unstructured":"Alkozi, H. A., Navarro, G., Aguinaga, D., Reyes-Resina, I., Sanchez-Naves, J., P\u00e9rez de Lara, M.\u00a0J., Franco, R., and Pintor, J. (2020) Adreno-melatonin receptor complexes control ion homeostasis and intraocular pressure - their disruption contributes to hypertensive glaucoma, Br.\u00a0J. Pharmacol., 9, 2090-2105, \nhttps:\/\/doi.org\/10.1111\/bph.14971.","journal-title":"Br.\u00a0J. Pharmacol."},{"key":"3056_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.21516\/2072-0076-2024-17-1-74-82","volume":"1","author":"V. V. Neroev","year":"2024","unstructured":"Neroev, V. V., Pavlenko, T. A., Chesnokova, N. B., Beznos, O. V., Okhotsimskaya, T. D., and Panova, A. Yu. (2024) Experimental substantiation of the use of thioctic acid and indomethacin at the early stage of the neurodegenerative process in the retina [in Russian], Russ. Ophthalmol. J., 1, 74-82, \nhttps:\/\/doi.org\/10.21516\/2072-0076-2024-17-1-74-82.","journal-title":"Russ. Ophthalmol. J."},{"key":"3056_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.biocel.2005.08.020","volume":"38","author":"R. Hardeland","year":"2006","unstructured":"Hardeland, R., Pandi-Perumal, S.\u00a0R., and Cardinali, D.\u00a0P. (2006) Melatonin, Int. J. Biochem. Cell Biol., 38, 313-316, \nhttps:\/\/doi.org\/10.1016\/j.biocel.2005.08.020.","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"3056_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107253","volume":"205","author":"J. Zhang","year":"2024","unstructured":"Zhang, J., Zhou, H., Cai, Y., Yoshida, S., Li, Y., and Zhou, Y. (2024) Melatonin: unveiling the functions and implications in ocular health, Pharmacol. Res., 205, 107253, \nhttps:\/\/doi.org\/10.1016\/j.phrs.2024.107253.","journal-title":"Pharmacol. Res."},{"key":"3056_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.70010","volume":"126","author":"P. Ghadimi","year":"2025","unstructured":"Ghadimi, P., and Ghorbian, S. (2025) Effects of melatonin on the expression of invasion-related markers (MMP2 and MMP9) in breast cancer cells, J. Cell Biochem., 126, e70010, \nhttps:\/\/doi.org\/10.1002\/jcb.70010.","journal-title":"J. Cell Biochem."},{"key":"3056_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1530\/JOE-12-0147","volume":"2","author":"W. Qin","year":"2012","unstructured":"Qin, W., Lu, W., Li, H., Yuan, X., Li, B., and Xiu, R. (2012) Melatonin inhibits IL1\u03b2-induced MMP9 expression and activity in human umbilical vein endothelial cells by suppressing NF-\u03baB activation, J.\u00a0Endocrinol., 2, 145-153, \nhttps:\/\/doi.org\/10.1530\/JOE-12-0147.","journal-title":"J.\u00a0Endocrinol."},{"key":"3056_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pharmthera.2013.11.002","volume":"1","author":"M. J. Giese","year":"2014","unstructured":"Giese, M. J., and Speth, R. C. (2014) The ocular renin-angiotensin system: a therapeutic target for the treatment of ocular disease, Pharmacol. Ther., 1, 11-32, \nhttps:\/\/doi.org\/10.1016\/j.pharmthera.2013.11.002.","journal-title":"Pharmacol. Ther."},{"key":"3056_CR34","doi-asserted-by":"publisher","first-page":"746","DOI":"10.18008\/1816-5095-2020-4-746-751","volume":"4","author":"L. A. Katargina","year":"2020","unstructured":"Katargina, L. A., Chesnokova, N. B., Beznos, O. V., Osipova, N. A., and Panova, A. Yu. (2020) Angiotensin-II as a trigger factor in the development of retinopathy of prematurity [in Russian], Oftal'mologiya, 4, 746-751, \nhttps:\/\/doi.org\/10.18008\/1816-5095-2020-4-746-751.","journal-title":"Oftal'mologiya"},{"key":"3056_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/521783","volume":"2013","author":"L. A. Campos","year":"2013","unstructured":"Campos, L. A., Cipolla-Neto, J., Amaral, F. G., Michelini, L.\u00a0C., Bader, M., Baltatu, O.\u00a0C. (2013) The Angiotensin-melatonin axis, Int.\u00a0J. Hypertens., 2013, 521783, \nhttps:\/\/doi.org\/10.1155\/2013\/521783.","journal-title":"Int.\u00a0J. Hypertens."},{"key":"3056_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26154666","volume":"15","author":"A. O. Sehirli","year":"2021","unstructured":"Sehirli, A. O., Sayiner, S., Chukwunyere, U., and Serakinci, N. (2021) Role of melatonin in angiotensin and aging, Molecules, 15, 4666, \nhttps:\/\/doi.org\/10.3390\/molecules26154666.","journal-title":"Molecules"},{"key":"3056_CR37","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10157-017-1505-7","volume":"3","author":"S. Ishigaki","year":"2017","unstructured":"Ishigaki, S., Ohashi, N., Matsuyama, T., Isobe, S., Tsuji, N., Iwakura, T., and Yasuda, H. (2017) Melatonin ameliorates intrarenal renin-angiotensin system in a 5\/6 nephrectomy rat model, Clin. Exper. Nephrol., 3, 539-549, \nhttps:\/\/doi.org\/10.1007\/s10157-017-1505-7.","journal-title":"Clin. Exper. Nephrol."},{"key":"3056_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejphar.2011.12.036","volume":"1-3","author":"L. Pernomian","year":"2012","unstructured":"Pernomian, L., Gomes, M. S., Restini, C. B., Ramalho, L. N., Tirapelli, C.\u00a0R., and de Oliveira, A.\u00a0M. (2012) The role of reactive oxygen species in the modulation of the contraction induced by angiotensin II in carotid artery from diabetic rat, Eur. J. Pharmacol., 1-3, 15-25, \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2011.12.036.","journal-title":"Eur. J. Pharmacol."},{"key":"3056_CR39","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41440-018-0186-2","volume":"6","author":"N. Ohashi","year":"2019","unstructured":"Ohashi, N., Ishigaki, S., and Isobe, S. (2019)\u00a0The pivotal role of melatonin in ameliorating chronic kidney disease by suppression of the renin-angiotensin system in the kidney, Hypertens. Res., 6, 761-768, \nhttps:\/\/doi.org\/10.1038\/s41440-018-0186-2.","journal-title":"Hypertens. Res."},{"key":"3056_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114591","volume":"162","author":"W. Zhang","year":"2023","unstructured":"Zhang, W., Wang, X., Tang, Y., and Huang, C. (2023) Melatonin alleviates doxorubicin-induced cardiotoxicity via inhibiting oxidative stress, pyroptosis and apoptosis by activating Sirt1\/Nrf2 pathway, Biomed. Pharmacother., 162, 114591, \nhttps:\/\/doi.org\/10.1016\/j.biopha.2023.114591.","journal-title":"Biomed. Pharmacother."},{"key":"3056_CR41","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.18632\/oncotarget.6407","volume":"7","author":"J. Lu","year":"2016","unstructured":"Lu, J., Fu, L., Tang, Z., Zhang, C., Qin, L., Wang, J., Yu, Z., Shi, D., Xiao, X., Xie, F., Huang, W., and Deng, W. (2016) Melatonin inhibits AP-2\u03b2\/hTERT, NF-\u03baB\/COX-2 and Akt\/ERK and activates caspase\/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells, Oncotarget, 7, 2985-3001, \nhttps:\/\/doi.org\/10.18632\/oncotarget.6407.","journal-title":"Oncotarget"},{"key":"3056_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.29413\/ABS.2021-6.3.14","volume":"3","author":"N. S. Khodzhaev","year":"2021","unstructured":"Khodzhaev, N. S., Chuprov, A. D., Kim, S. M., Marshinskaya, O. V., and Kazakova, T. V. (2021) Melatonin level as a risk factor for the development of age-related macular degeneration, Acta Biomed. Sci., 3, 133-141, \nhttps:\/\/doi.org\/10.29413\/ABS.2021-6.3.14.","journal-title":"Acta Biomed. Sci."},{"key":"3056_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073999","volume":"7","author":"A. Romeo","year":"2024","unstructured":"Romeo, A., Kazsoki, A., Musumeci, T., and Zelk\u00f3, R. (2024) A clinical, pharmacological, and formulation evaluation of melatonin in the treatment of ocular disorders-a systematic review, Int. J. Mol. Sci., 7, 3999, \nhttps:\/\/doi.org\/10.3390\/ijms25073999.","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297925603880.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297925603880","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297925603880.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:07:25Z","timestamp":1787980045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297925603880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3056"],"URL":"https:\/\/doi.org\/10.1134\/s0006297925603880","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"1 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      All experiments with animals were carried out in accordance with the rules established by GOST 33215-2014 \u201cGuidelines for the Care and Use of Laboratory Animals\u201d and the recommendations of the \u201cStatement for the Use of Animals in Ophthalmic and Visual Research\u201d of the Association for Research in Vision and Ophthalmology (ARVO). The protocol of this study was approved by the Ethics Committee of the Helmholtz National Medical Research Center of Eye Diseases of the Ministry of Health of Russia (Protocol no. 63\/1, dated December\u00a01, 2022).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}